LIVALO pitavastatin 4 mg film-coated tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

pitavastatin calcium, Quantity: 4.18 mg (Equivalent: pitavastatin, Qty 4 mg)

Tilgjengelig fra:

Advantage Medical Products Consulting Pty Ltd

INN (International Name):

pitavastatin calcium

Legemiddelform:

Tablet, film coated

Sammensetning:

Excipient Ingredients: aluminium magnesium silicate; lactose monohydrate; hypromellose; triethyl citrate; magnesium stearate; hyprolose; titanium dioxide; colloidal anhydrous silica

Administreringsrute:

Oral

Enheter i pakken:

100, 10, 30, 28

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Livalo is indicated as an adjunct to diet for the treatment of adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia, when response to diet and other non-pharmacological measures is inadequate. Prior to initiating therapy with Livalo, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.

Produkt oppsummering:

Visual Identification: Round biconvex white film-coated tablets embossed on one side with 'KC' and '4' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisasjon status:

Licence status A

Autorisasjon dato:

2013-08-27